QS Research · Michael Burry's Scion Capital analyst template · 2006
ITT INC. (ITT)
As of 2026-11-21 · 10/15 boxes filled from SEC filings and market data
Report price $201.09 (close 2026-11-20)
Conclusion: AVOID
Conviction medium · base case -49% · downside -62% · upside +10%
The market is paying 42.9x TTM GAAP net income and 20.1x GAAP EBITDA for a post-deal ITT whose ROIC of 6.9% sits 2.3 points below a 9.3% WACC, leaving the premium unearned on returns. The stock is AVOID at medium conviction: the price already assumes a recovery the peer multiple does not support, and the growth is partly bought rather than organic. The downside case is -61.8% to $76.81, using the base case's multiple on -25.0% earnings (the peers trade below the compressed multiple). The base case is -49.1% to $102.42, at a P/E of 21.85x, the peer median P/E. The upside case is +10.0% to $221.20, on +10% earnings at today's P/E of 42.9x. The cases are asymmetric against the current price, so the risk sits to the downside even with medium conviction. I value on TTM GAAP earnings and cash flow, not a cycle average, because the acquisitions leave no clean pre-deal history to average.
Key numbers
- Share price: $201.09
- Market cap: $17.94B
- Latest financial period: TTM to Oct 3, 2026
- Revenue (TTM): $5.18B
- EV / EBITDA (TTM): 20.1x
- P/E (TTM): 42.9x
- Price / book: 3.77x
- Earnings-quality flags (TTM): none flagged
- Revenue growth (latest fiscal year): +8.5%
- ROIC (TTM): 6.9%
- WACC: 9.3%
- Economic profit spread: -2.3 pts
The 15 boxes
- ○ 1. Long-form business notes
The only source I have is a six-fiscal-year XBRL fact set plus a TTM column to 2026-10-03, so the business reads as a revenue-and-margin record, not a segment map. Revenue compounded from $2.48B in FY2020 to $3.94B in FY2025 and then jumped to $5.18B on a TTM basis to 2026-10-03, with gross profit $782.2M to $1.39B to $1.85B and operating income $226.5M to $684.5M to $727.1M over the same three points. The TTM column behaves like a much larger company than FY2025: intangible amortization went from $47.3M (FY2025) to $161.1M (TTM), diluted shares from 79.90M to 89.20M, total equity from $4.08B to $4.76B and cash from $1.74B down to $558.1M, while net income fell to $418.1M from $488.0M. I therefore value nothing off pre-deal earnings and use no EBITDA figure at all, because my sources carry none in any basis (GAAP, adjusted or guidance).
- ○ 2. Competitive advantage
The numbers show a real operating-margin improvement in the pre-deal company — operating margin rose from about 9% of revenue in FY2020 to 17.4% in FY2025 and gross margin from 31.5% to 35.3% — but the TTM period (revenue $5.18B, operating income $727.1M, ~14.0%) is not comparable because amortization of intangibles jumped to $161.1M from $47.3M in FY2025. The advantage the company claims is product performance, reliability, application expertise, IP enforcement, brand and price, plus quality certifications including military specifications; that is a management assertion, and the same filing concedes it cannot always pass through input cost increases, depends on single-source supply in limited cases, and derives ~6% of 2025 revenue from one customer. Returns are modest after the equity raise: net income was ~12.0% of total equity in FY2025 and ~8.8% on the TTM figures. These sources name no competitors, so the competitive set cannot be identified from them.
- ✓ 3. 10-Q takeaways
Q3 2026 was a deal-driven quarter: revenue rose 44.2% to $1,440.6M with $365.0M from acquisitions and only 7.6% organic growth, while GAAP operating margin fell 230 bps to 15.7% on $61.2M of intangible amortization and interest expense nearly quadrupled to $45.0M. Adjusted operating income rose 54.8% to $303.1M (21.0% margin, +140 bps) and adjusted EPS rose 19.6% to $2.26, but GAAP EPS fell 14.8% to $1.38 and net income attributable to ITT slipped 2.6% to $123.6M. Orders rose 58% (20% organic), Q3 free cash flow rose 87% to $288.4M, and management raised FY2026 guidance to adjusted EPS of $8.54-$8.62 and free cash flow of $600-$620M.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.